Inverness Counsel’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.77M | Sell |
45,782
-971,816
| -96% | -$37.6M | 0.1% | 67 |
|
|
2022
Q2 | $37.9M | Sell |
1,017,598
-29,119
| -3% | -$1.09M | 2.13% | 13 |
|
|
2022
Q1 | $46.4M | Buy |
1,046,717
+464,710
| +80% | +$20.6M | 2.08% | 13 |
|
|
2021
Q4 | $24.7M | Sell |
582,007
-731,513
| -56% | -$31.1M | 0.91% | 31 |
|
|
2021
Q3 | $57M | Buy |
1,313,520
+16,217
| +1% | +$704K | 2.09% | 16 |
|
|
2021
Q2 | $55.5M | Sell |
1,297,303
-45,669
| -3% | -$1.95M | 2.02% | 16 |
|
|
2021
Q1 | $51.9M | Buy |
1,342,972
+274,387
| +26% | +$10.6M | 2.14% | 13 |
|
|
2020
Q4 | $38.4M | Sell |
1,068,585
-241,598
| -18% | -$8.69M | 1.57% | 25 |
|
|
2020
Q3 | $50.1M | Buy |
1,310,183
+745,886
| +132% | +$28.5M | 2.24% | 12 |
|
|
2020
Q2 | $19.8M | Buy |
+564,297
| New | +$19.8M | 0.99% | 33 |
|